Suppr超能文献

肾移植后选择性晚期停用类固醇

Selective late steroid withdrawal after renal transplantation.

作者信息

Laube Guido F, Falger Jutta, Kemper Markus J, Zingg-Schenk Andrea, Neuhaus Thomas J

机构信息

Nephrology Unit, University Children's Hospital, Steinwiesstrasse 75, CH-8032, Zurich, Switzerland.

出版信息

Pediatr Nephrol. 2007 Nov;22(11):1947-52. doi: 10.1007/s00467-007-0576-1. Epub 2007 Sep 14.

Abstract

Steroid withdrawal (SW) after paediatric renal transplantation (RTPL) is controversial. Selective late SW has been performed in our unit since 1995. The safety and effects of SW were analysed retrospectively in 47 patients undergoing RTPL between 1995 and 2004. Initial immunosuppression consisted of cyclosporine A, azathioprine or mycophenolate mofetil and steroids. Criteria for SW were: (1) stable renal function, (2) time interval after RTPL > or = 1 year, (3) no rejection or time interval after last rejection > or = 1 year and (4) good compliance. SW was performed in 30 patients at an age of 13.5 years (range 4.5-18.5) and 2.2 years (range 1-6.6) after RTPL. After SW, one patient experienced a steroid-sensitive rejection. Follow-up after SW (1.3 year; range 0.25-7.5) showed maintained renal function: glomerular filtration rate at SW and currently was 82 (65-128) and 82 (42-115) ml/min per 1.73 m(2), respectively. The number of patients on antihypertensive treatment did not significantly change (at SW: n = 15; currently: n = 11). Height and body mass index (BMI) remained stable: Median standard deviation score (SDS) for height/BMI at SW and currently was -1.1/0.2 and -0.8/0.1, respectively. Selective late SW was safe regarding renal function and had no significant effect on blood pressure and growth.

摘要

小儿肾移植(RTPL)后停用类固醇(SW)存在争议。自1995年以来,我们科室一直进行选择性晚期SW。对1995年至2004年间接受RTPL的47例患者的SW安全性和效果进行了回顾性分析。初始免疫抑制包括环孢素A、硫唑嘌呤或霉酚酸酯以及类固醇。SW的标准为:(1)肾功能稳定;(2)RTPL后时间间隔≥1年;(3)无排斥反应或上次排斥反应后时间间隔≥1年;(4)依从性良好。30例患者在RTPL后13.5岁(范围4.5 - 18.5岁)和2.2年(范围1 - 6.6年)时进行了SW。SW后,1例患者发生了类固醇敏感型排斥反应。SW后的随访(1.3年;范围0.25 - 7.5年)显示肾功能维持良好:SW时和目前的肾小球滤过率分别为每1.73 m² 82(65 - 128)和82(42 - 115)ml/min。接受降压治疗的患者数量无显著变化(SW时:n = 15;目前:n = 11)。身高和体重指数(BMI)保持稳定:SW时和目前身高/BMI的中位标准差评分(SDS)分别为-1.1/0.2和-0.8/0.1。选择性晚期SW在肾功能方面是安全的,对血压和生长无显著影响。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验